| Clave |
1944 |
| Nombre del Convenio o Proyecto Patrocinado |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a shar |
| Fecha de Inicio |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a |
| Fecha de Culminación (tentativo) |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a |
| Objetivos del Proyecto |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
| Personal del área que Participa en el Proyecto Patrocinado |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
| Instituciones Participantes (en su caso) |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
| Justificacion |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
| Numero Economico |
0 |
| Fecha_registro |
2022-06-27 18:56:52 |